Moneycontrol PRO
you are here: HomeNewsGsk
Jump to
86 Results Found
  • Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India Jul 09, 2021 09:00 AM IST

    Sanofi, GSK get approval to conduct phase 3 trial of COVID-19 vaccine in India

    In a two-stage approach, the phase 3 clinical study will initially investigate the efficacy of the COVID-19 vaccine formulation targeting the original novel coronavirus strain.

  • COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report Jul 07, 2021 09:12 AM IST

    COVID-19 vaccine | Sanofi to seek permission for Phase 3 trial in India: Report

    Sanofi is looking to conduct a part of its 35,000-participant global Phase 3 trial of its COVID-19 vaccine in India.

  • COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study May 17, 2021 12:35 PM IST

    COVID-19 Vaccine | Sanofi and GSK’s vaccine said to produce strong immune responses in mid-stage study

    The vaccine hit a major setback in December, when its developers announced that it did not appear to work well in older adults and that they would have to delay plans to test it in a Phase 3 trial, the crucial test that will assess the vaccine’s effectiveness.

  • Meet Sudhir Sitapati, Godrej consumer’s new top boss May 12, 2021 10:32 PM IST

    Meet Sudhir Sitapati, Godrej consumer’s new top boss

    GCPL’s stock soared the most since it went public following the announcement of the new Managing Director and CEO, Sudhir Sitapati – an HUL veteran.

  • Glenmark Pharma’s Kaizad Hazari to become General Counsel of Arcelor Mittal Nippon Steel India; Ex- Dr Reddy’s Suprio Dasgupta to replace Hazari Apr 17, 2021 07:00 PM IST

    Glenmark Pharma’s Kaizad Hazari to become General Counsel of Arcelor Mittal Nippon Steel India; Ex- Dr Reddy’s Suprio Dasgupta to replace Hazari

    Kaizad Hazari has more than 28 years of experience and has previously worked with HDFC Ltd, GSK, Hindalco Industries, Raymonds, Asian Paints and ICICI Bank. Prior to Dr Reddy’s, Dasgupta, an alumnus of the NLSIU Bangalore 1994 LLM batch, has had stints at Schneider Electric, International Paper , Honeywell International, General Electric and the United Nations High Commission for Refugees.

  • GSK, Sanofi begin new COVID-19 vaccine trial after setback last year Feb 22, 2021 05:41 PM IST

    GSK, Sanofi begin new COVID-19 vaccine trial after setback last year

    The move comes after the drugmakers in December said their vaccine would be delayed after clinical trials showed an insufficient immune response in older people.

  • GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants Feb 03, 2021 01:35 PM IST

    GSK, CureVac partnership eyes COVID-19 vaccine against multiple variants

    In a joint statement on Wednesday, the partners said they were targeting a possible launch in 2022.

  • GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance Oct 28, 2020 12:35 PM IST

    GSK, Sanofi to make 200 million doses available for COVID-19 vaccine alliance

    COVAX aims to deliver 2 billion vaccine doses around the world by the end of 2021, and more than 180 nations have joined the plan.

  • GlaxoSmithKline to launch late-stage testing of syncytial virus vaccine Oct 21, 2020 10:31 AM IST

    GlaxoSmithKline to launch late-stage testing of syncytial virus vaccine

    RSV vaccine development has been fraught with setbacks for decades but the pharma industry is gearing up to bring a first inoculation to market over the next few years.

  • Sanofi and GSK launch trial for COVID-19 protein-based vaccine Sep 03, 2020 11:02 AM IST

    Sanofi and GSK launch trial for COVID-19 protein-based vaccine

    Sanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world.

  • Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK Jul 29, 2020 11:30 AM IST

    Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK

    Financial terms of the agreement were not disclosed. Sanofi and GSK, which had first teamed up in April, confirmed in a statement that regulatory approval for their vaccine could be achieved by the first half of 2021 if clinical data was to be positive.

  • Britain's GSK to take 10% stake in Germany's CureVac for $163 million Jul 20, 2020 12:10 PM IST

    Britain's GSK to take 10% stake in Germany's CureVac for $163 million

    CureVac's existing COVID-19 mRNA and rabies vaccines research programmes are not included in the deal, the companies said.

  • COVID-19 vaccine | Britain nears 500 million pound deal with GSK, Sanofi: Report Jul 05, 2020 02:02 PM IST

    COVID-19 vaccine | Britain nears 500 million pound deal with GSK, Sanofi: Report

    Britain is considering an option to buy the vaccine if human trials, which are due to begin in September, are successful.

  • GSK in quest to be best, not first, in race for COVID-19 vaccine Jun 20, 2020 12:21 PM IST

    GSK in quest to be best, not first, in race for COVID-19 vaccine

    According to the British group's chief medical officer for vaccines Thomas Breuer, who says the company prefers the slow and steady approach of focusing on an established technology that has the best chance of reaching the widest possible demographic.

  • GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy Jun 11, 2020 05:03 PM IST

    GSK is world's largest vaccine maker. Yet it has been tame with its COVID-19 strategy

    GSK is betting on its adjuvant technology to support companies developing COVID-19 vaccines.

  • GSK to produce 1 billion doses of coronavirus vaccine booster in 2021 May 28, 2020 02:44 PM IST

    GSK to produce 1 billion doses of coronavirus vaccine booster in 2021

    The London-listed company said it was in talks with governments on backing for the programme, which would effectively allow for a scaling up of production of future successful vaccines

  • GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever May 07, 2020 02:35 PM IST

    GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever

    The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.

  • GSK, Horlicks to sell 5.69% stake in HUL via block deals worth $3.2-3.4 billion May 06, 2020 04:41 PM IST

    GSK, Horlicks to sell 5.69% stake in HUL via block deals worth $3.2-3.4 billion

    The price band for the block deals has been set between Rs 1,850 to Rs 1,950 a share

  • Coronavirus pandemic | Sanofi, GSK come together to develop vaccine for COVID-19 Apr 15, 2020 10:22 AM IST

    Coronavirus pandemic | Sanofi, GSK come together to develop vaccine for COVID-19

    As per the partnership, France-based Sanofi will contribute its S-protein COVID-19 antigen, which is based on recombinant DNA technology.

  • Steer Engineering reaches out-of-court settlement with GSK over Horlicks Jan 07, 2020 02:35 PM IST

    Steer Engineering reaches out-of-court settlement with GSK over Horlicks

    GSK's nutrition business is largely led by the Horlicks brand.

  • Chiron Behring relaunches rabies vaccine under ChiroRab brand Nov 13, 2019 03:51 PM IST

    Chiron Behring relaunches rabies vaccine under ChiroRab brand

    Bharat Biotech acquired Chiron Behring from GSK in March this year and commercial operations at the company's Ankleshwar (Gujarat) unit restarted in May.

  • Reporter's Take | Government scrambles to address shortage of rabies vaccine Sep 03, 2019 07:16 PM IST

    Reporter's Take | Government scrambles to address shortage of rabies vaccine

    The National Pharmaceutical Pricing Authority has asked manufacturers and distributors to immediately supply stocks in areas where a shortage has been reported.

  • GSK appoints HSBC's Jonathan Symonds as non-executive chairman Jul 24, 2019 05:30 PM IST

    GSK appoints HSBC's Jonathan Symonds as non-executive chairman

    Incoming chairman Symonds is currently deputy group chairman at banking group HSBC, where he has also been an independent non-executive director since April 2014.

  • Bharat Biotech acquires Chiron Behring Vaccines from GSK for undisclosed amount Feb 15, 2019 06:42 PM IST

    Bharat Biotech acquires Chiron Behring Vaccines from GSK for undisclosed amount

    The acquisition allows Hyderabad-headquartered Bharat Biotech to become world's largest manufacturer of rabies vaccines.

  • GSK Chairman Philip Hampton to step down Jan 21, 2019 01:17 PM IST

    GSK Chairman Philip Hampton to step down

    Before joining GSK, Hampton was chairman of Royal Bank of Scotland Group Plc and J Sainsbury plc .

Sections
ISO 27001 - BSI Assurance Mark